Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Gregory O. MalcolmExec. VP & Controller | -2,30k | 203,41k | Verkauf | 88,44 | 22,20k | -9,39% |
| 2026-05-07 | Ms. Sally MasseyChief HR Officer | -8,60k | 751,63k | Verkauf | 87,41 | 21,94k | -28,16% |
| 2026-02-23 | Mr. John HazlinChief Growth Officer | -6,12k | 593,96k | Sale to Issuer | 97,10 | 29,87k | -17,00% |
| 2026-02-23 | Ms. Jennifer M. DanielsVice Chair | -12,35k | 1,20M | Sale to Issuer | 97,10 | 91,68k | -11,87% |
| 2026-02-23 | Mr. Stanley J. SutulaCFO | -19,75k | 1,92M | Sale to Issuer | 97,10 | 74,65k | -20,92% |
| 2026-02-23 | Mr. Gregory O. MalcolmExec. VP & Controller | -2,26k | 219,45k | Sale to Issuer | 97,10 | 24,45k | -8,46% |
| 2026-02-23 | Ms. Sally MasseyChief HR Officer | -8,21k | 796,80k | Sale to Issuer | 97,10 | 30,50k | -21,20% |
| 2026-02-23 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -13,08k | 1,27M | Sale to Issuer | 97,10 | 88,44k | -12,89% |
| 2026-02-23 | Mr. Noel R. WallaceChairman, CEO & President | -68,25k | 6,63M | Sale to Issuer | 97,10 | 468,54k | -12,71% |
| 2026-02-11 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -50,00k | 957,94k | Derivative Exercise and Sale | 76,41 - 97,81 | 75,73k | - |
| 2026-02-10 | Mr. John HazlinChief Growth Officer | -20,99k | 374,44k | Derivative Exercise and Sale | 76,41 - 94,25 | 23,10k | - |
| 2026-02-06 | Mr. Gregory O. MalcolmExec. VP & Controller | -12,75k | 235,82k | Derivative Exercise and Sale | 76,41 - 94,91 | 20,43k | - |
| 2026-02-05 | Ms. Sally MasseyChief HR Officer | -15,85k | 295,11k | Derivative Exercise and Sale | 76,41 - 95,03 | 21,86k | - |
| 2026-02-04 | Mr. Stanley J. SutulaCFO | -97,84k | 1,22M | Derivative Exercise and Sale | 81,78 - 94,27 | 55,64k | - |
| 2026-02-04 | Ms. Jennifer M. DanielsVice Chair | -22,00k | 485,02k | Derivative Exercise and Sale | 72,29 - 94,34 | 78,24k | - |
| 2026-02-04 | Mr. Noel R. WallaceChairman, CEO & President | -45,57k | 4,28M | Verkauf | 93,91 | 399,80k | -10,23% |
| 2025-12-03 | Mr. Stanley J. SutulaCFO | -385,00 | 30,11k | Sale to Issuer | 78,20 | 55,64k | -0,69% |
| 2025-12-03 | Mr. Noel R. WallaceChairman, CEO & President | -1,31k | 102,21k | Sale to Issuer | 78,20 | 445,01k | -0,29% |
| 2025-12-03 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -221,00 | 17,28k | Sale to Issuer | 78,20 | 75,70k | -0,29% |
| 2025-12-03 | Mr. John HazlinChief Growth Officer | -156,00 | 12,20k | Sale to Issuer | 78,20 | 23,06k | -0,67% |
| 2025-12-03 | Mr. Gregory O. MalcolmExec. VP & Controller | -41,00 | 3,21k | Sale to Issuer | 78,20 | 20,38k | -0,20% |
| 2025-12-03 | Ms. Jennifer M. DanielsVice Chair | -213,00 | 16,66k | Sale to Issuer | 78,20 | 78,23k | -0,27% |
| 2025-11-21 | Ms. Sally MasseyChief HR Officer | -1,24k | 100,06k | Verkauf | 80,89 | 21,81k | -5,37% |
| 2025-09-12 | Ms. Jennifer M. DanielsVice Chair | -1,42k | 118,34k | Sale to Issuer | 83,28 | 78,37k | -1,78% |
| 2025-09-12 | Mr. Gregory O. MalcolmExec. VP & Controller | -241,00 | 20,07k | Sale to Issuer | 83,28 | 20,35k | -1,17% |
| 2025-09-12 | Mr. John HazlinChief Growth Officer | -826,00 | 68,79k | Sale to Issuer | 83,28 | 23,01k | -3,47% |
| 2025-09-12 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -1,42k | 118,34k | Sale to Issuer | 83,28 | 75,83k | -1,84% |
| 2025-09-12 | Mr. Stanley J. SutulaCFO | -2,14k | 177,89k | Sale to Issuer | 83,28 | 55,92k | -3,68% |
| 2025-09-12 | Ms. Prabha ParameswaranInsider | -1,68k | 139,74k | Sale to Issuer | 83,28 | 63,78k | -2,56% |
| 2025-09-12 | Ms. Sally MasseyChief HR Officer | -1,12k | 92,94k | Sale to Issuer | 83,28 | 22,95k | -4,64% |
| 2025-09-12 | Mr. Noel R. WallaceChairman, CEO & President | -7,75k | 645,34k | Sale to Issuer | 83,28 | 445,61k | -1,71% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
